These Healthcare stocks are trading higher:
-Cumberland Pharmaceuticals, Inc. (CPIX) stock is trading at $6.92, a rise of $2.33, or 49.89%, on moderate volume. Cumberland Pharmaceu gets a Sentiment Score of Neutral from InvestorsObserver.
-Vyne Therapeutics Inc (VYNE) stock is trading at $1.19, a gain of $0.28, or 30.7%, on high volume. Vyne Therapeutics Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $6.50.
-Adicet Bio Inc (ACET) stock is trading at $12.83, a rise of $3.03, or 29.9%, on high volume. Adicet Bio Inc gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $27.00.
-eFFECTOR Therapeutics Inc (EFTR) stock is trading at $7.31, a gain of $1.6, or 28.08%, on high volume. Effector Therapeutics Inc gets a Sentiment Score of Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.75.
Find the top stocks in the Healthcare Sector here.
These Healthcare stocks are trading lower:
-Bolt Biotherapeutics Inc (BOLT) stock is trading at $5.18, a loss of $5.32, or 50.71%, on high volume. Bolt Biotherapeutics Inc gets a Sentiment Score of Bullish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $38.50.-Reata Pharmaceuticals Inc (RETA) stock is trading at $48.50, a decline of $30.19, or 38.26%, on high volume. Reata Pharma gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $220.63.
-Aeglea Bio Therapeutics Inc (AGLE) stock is trading at $4.00, a drop of $2, or 33.29%, on high volume. Aeglea Biothera gets a Sentiment Score of Neutral from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $13.25.
-Finch Therapeutics Group Inc (FNCH) stock is trading at $11.13, a drop of $4.19, or 27.35%, on high volume. Finch Therapeutics Group Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of $30.00.
